About Gentium
Gentium S.p.A. is public biopharmaceutical company specializing in the discovery, research, development and manufacture of active ingredients derived from natural sources as potential therapeutic agents.
Advertisement
Product portfolio of Gentium
Here you will find Gentium S.p.A.
Last viewed contents
ProBioGen expands protein and virus manufacturing to drive continued growth
Antiverse - Cardiff, United Kingdom
BASF lifts force majeure for key vitamin A and E products
NextPharma announces the appointment of Ajeeth Enjeti as CEO to succeed Peter Burema
Fermify GmbH - Vienna, Austria
Fair Rules for Sharing Sequence Data: New roadmap in Nature Microbiology - Combining openness and fairness in the data-intensive life sciences
Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany - Change in the Executive Board from September 1, 2025
Opening the door to affordable lab-grown beef, cow cells defy aging - A potential game-changer for creating sustainable, ethical meat without the environmental toll of traditional livestock farming
Analytica USA celebrated its premiere on the US market - Key topics: digitalization and sustainability in the laboratory
"A DNA search engine" searches through millions of data records in seconds - This can significantly accelerate research into antibiotic resistance and unknown pathogens
Pancreatic cancer forms "synapses" - Pancreatic tumors use neurotransmitters to drive their own growth: Researchers hope to identify drugs that can block this process